The Best Cancer Therapy

The most common type of cancer in men is the prostate cancer, and even if it is one of the most dreaded conditions, once diagnosed at its early stages, it is curable. In WHO cancer statistics, new cases of this disease continue being reported, and they predict an uptrend of these cases in the years to come. The most excellent proposed way out of this enigma is regular checkups that would help in early diagnosis hence early treatment to cure the condition.

Symptoms of Prostate Cancer

The early signs of this condition are asymptomatic; this is to mean that there are no known signs until the disease has advanced. However, the following are some of the symptoms that result from the manifestation of prostate cancer at its various stages.

· Regular need to urinate

· inability to get and keep an erection,

· hematuria,

· Difficulty in urinating.

At advanced stage, the following are the signs,

· Pain in the nearby skeletal bones such the pelvic bone, the spine, and femur

· Risk of fracture to these bones

· Problem with defecation

Treatment of Prostate Cancer

The treatment procedure of all type of cancer follows a laid out protocol and involves a series of treatments. Among them are the chemotherapy and radiotherapy which can also be used to treat prostate cancer. However, the most efficient and most recent treatment method is the 3D cancer treatment.

What are some of the approaches that are making the 3D prostate cancer treatment the best?

· The first approach that sets the procedure apart from the rest is that it first relies on the determination of the real causative pathogens. By these, it makes it easy for targeted treatment and avoids damaging other healthy cells which are a standard issue in radiotherapy. This form of isolation and determination improves the specificity of the procedure to eradicate the condition altogether.

· After the above step, the second unique protocol; is the destruction of the causative cells by direct injection of an anticancer drug that completely wipes out these cancerous cells. This form of treatment has many advantages than any other in that it guarantees that the condition does not reoccur at any given time.

· The last approach is usually the cleanup stage where the cellular debris and the necrotic cells are channeled out of the body in a secure manner and in a way that cleans up the system entirely.


Anyone intending to look for the best prostate cancer treatment need not look any further because 3D targeted cancer treatment is here for them.

Psa Bounce After Radiation Therapy For Prostate Cancer: Keeping An Eye On The Ball

Prostate specific antigen (PSA) is a protein produced by the prostate gland. It is measured in the blood stream and is a useful tool for following men who have been treated for prostate cancer. Does a PSA elevation after radiation treatment, be it a prostate seed implant and/or external beam radiation therapy, always signify disease recurrence?

In the past, a PSA elevation after a prostate seed implant or external beam radiation therapy was considered to be a harbinger of a prostate cancer relapse, often prompting expensive tests and invoking a great deal of patient anxiety. Then, when the PSA level climbed to10 ng/ml or greater, men were placed on hormonal therapy. Since the latter is associated with a number of unpleasant side effects, it is desirable to refrain from using hormonal therapy unless necessary. The question then arises: when does an increase in the PSA level not signify that cancer has returned?

There is a phenomenon known as a PSA bounce, in which the PSA level jumps up within one to three years after the man has completed radiation therapy. The PSA level eventually returns to the baseline it attained just after treatment. PSA bounce may be caused by death of the damaged cancer cells that release their PSA.

A PSA bounce usually begins with less than a one-point (less than 1 ng/ml) rise in the PSA level. Also, elevations of the PSA level after three years are less likely to be part of a bounce, and unlike a bounce, rises of the PSA level by more than 1.2ng/ml are less likely to drop back to their starting points.

A recent study collected data on 7,500 men who were treated for prostate cancer with radiation therapy. Nearly half of these men were found to have a PSA bounce. However, there was no adverse effect on their survival. In fact, these men fared just as well as men whose PSA did not bounce. Also, patients who show such a PSA bounce less than two years after treatment may be less likely to have cancer return later.

More good news is now that physicians are aware that an elevation in the PSA level does not necessarily mean prostate cancer has recurred, men whose PSA bounces after radiation therapy can be followed by their doctors, who can repeat the PSA blood test six months later.

Confusion About Testosterone Therapy and Prostate Cancer

One of the most commonly cited side effects for hormone replacement therapy as a cure to low testosterone in men is an increased risk of prostate cancer. However, much like with the Million Woman Study that linked HRT and breast cancer, the evidence corroborating this belief is dated and likely false. In fact, according to some modern research, low testosterone is actually a risk factor FOR types of male cancer.

The origins of the theory that testosterone replacement increased the risk of prostate cancer go back to research done at the University of Chicago in the 1940s by a group led by urologist Charles Huggins. Based on experiments performed first on dogs and then on humans, Huggins’ group concluded that prostate cancer was androgen dependent – when testosterone levels were high, the cancer worsened, but when the levels were lowered, the cancer shrank. Huggins’ theory led to surgical castration – removal of the testicles – becoming the standard treatment for prostate cancer because of the resultant drop in testosterone. Huggins was awarded a Nobel Prize in 1966 for these contributions to medical research.

Huggins’ findings led scientists and doctors to believe for many years that testosterone levels and prostate cancer occurrence were linked, despite the fact that his experiments didn’t test nor prove this and were limited to small numbers of test subjects. This caused medical professionals to be skeptical of hormone replacement therapy, fearing that it could lead to the development of prostate cancer. Many shied away from prescribing HRT, despite its benefits.

As time went on, more research was done, and studies showed that men with low testosterone seemed to develop prostate cancer at a higher than average rate, and that testosterone only caused progression of cancer of the prostate in men who had been castrated, and not in men who still produced testosterone naturally. The supposed link between testosterone and prostate cancer had to be reexamined.

Eventually, the medical community began to change its tune as it was presented with new evidence. A number of studies done in the 2000s, including ones published by the New England Journal of Medicine and the Mayo Clinic, showed no correlation between elevated testosterone levels and cancer of the prostate. Separate studies done by Abraham Morgentaler, a leading doctor in the field, showed that raising the levels of testosterone in men already diagnosed with prostate cancer caused no further progression of the disease, and that men in the lower range of testosterone levels are actually more at risk of developing prostate cancer than men with higher amounts. It’s now become clear that the relationship between testosterone and cancer of the prostate was misunderstood for much of the 20th century, and that hormone replacement as a means of supplementing low testosterone levels in men won’t cause the disease.

So if you’re a man who suspects he may have low testosterone, and are considering hormone replacement therapy, you can rest easy. HRT won’t give you prostate cancer; in fact, it might help prevent it.